$USAQ 2021 Financial Results
Total assets for the year ended December 31, 2021 were $2,208,497, compared to $297,863 the same period in 2020
Total revenues for the year ended December 31, 2021 were $1,414,421, compared to $124,532 revenues in the comparable period of 2020
The Company generated a gross profit of $670,748, or a gross margin of approximately 47.4% during the year ended December 31, 2021
QHSLab, the flagship product of USA Equities Corp, has garnered tremendous brand recognition. We have decided to change the name of our Company to QHSLab, Inc. pending FINRA approval expected in April 2022.
Our Operating Model
Our mission is to enhance the quality of life of individuals and populations through physician-directed digital medicine and innovative, artificial intelligence (AI) enhanced preventive health technologies.
Value Based. The Company provides the tools that enhance health care for patients while lowering costs to insurance providers and corporate America and allowing physicians to increase their practice revenues.
Patient Centered. Our products streamline the relationship between physicians and their patients, providing a high-quality experience for patients, and increasing the value provided to them during care.
Time Saving. Physicians can maximize face-to-face office visits and non-face-to-face patient education while generating additional revenue through reimbursable preventative services.
Prevention Focused. Our products are designed to promote prevention, early detection, management, and reversal of chronic diseases.
Executing our Growth Strategy
Growing Recurring Revenue Base
Increasing the number of medical practitioners utilizing our point-of-care and digital medicine services, growing our revenue per client metric.
Future distribution channels include Management Service Organization (MSO) partnerships, Independent Physician Associations (IPA’s), and complementary digital health networks.
Expanding Product Portfolio
Additional point-of-care diagnostic, digital medicine, and treatments that PCPs can use, prescribe, and be reimbursed for under existing government and private insurance programs.
Increasing Industry Visibility
Increasing the number of company/university-sponsored medical conferences by partnering with the University of Miami to introduce and educate members of the medical community about the technology and revenue opportunities available.
